Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

January 15, 2021

External validation of INCREMENT-CPE score in a retrospective cohort of carbapenemase-producing Klebsiella pneumoniae bloodstream infections in critically ill patients

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Matthaios Papadimitriou-OlivgerisMarkos Marangos
January 12, 2021
Open Access

Trends in Dental Medication Prescribing in Australia during the COVID-19 Pandemic

JDR Clinical and Translational Research
M MianM Hopcraft
January 15, 2021

Amoxicillin/clavulanic acid-associated severe neutropenia

Postgraduate Medical Journal
Ami Schattner, Ina Dubin
January 14, 2021
Preprint
Open Access

An ancient motif unique for human STING, RGS12 and SARS-CoV-2 spike proteins

ResearchSquare
Suleyman Aydin, Ayca Cakmak Aydin
January 13, 2021

Structural and biochemical characterization of the novel CTX-M-151 extended-spectrum β-lactamase and its inhibition by Avibactam

Antimicrobial Agents and Chemotherapy
Barbara GhiglionePablo Power
January 12, 2021
Open Access

Crystal structure of AmpC BER and molecular docking lead to the discovery of broad inhibition activities of halisulfates against β-lactamases

Computational and Structural Biotechnology Journal
Bo-Gyeong JeongSun-Shin Cha
January 15, 2021
Open Access

Biotin-Labelled Clavulanic Acid to Identify Proteins Target for Haptenation in Serum: Implications in Allergy Studies

Frontiers in Pharmacology
Ángela Martín-SerranoMaría I Montañez
January 23, 2021

Virulent and multidrug-resistant Klebsiella pneumoniae from clinical samples in Balochistan.

International Wound Journal
Sareeen FatimaAdnan Khan
December 31, 2020

Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients

The Journal of Antimicrobial Chemotherapy
Marco FalconeManjunath P Pai
January 24, 2021

Evaluation of amoxicillin-clavulanic acid resistance in the Bifidobacterium genus.

Applied and Environmental Microbiology
Leonardo MancabelliFrancesca Turroni

Sign up to follow this feed and discover related papers.

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2021 Meta ULC. All rights reserved
/feed-previews/beta-lactamase-inhibitors/e3c3f45e-0368-4b37-8375-68080d1877dd